Suresh S. Ramalingam, MD, FASCO Profile
Suresh S. Ramalingam, MD, FASCO

@RamalingamMD

Followers
6K
Following
8K
Media
160
Statuses
1K

Executive Director @WinshipAtEmory | Professor @EmoryUniversity |Associate VP for Cancer, Woodruff Health Sciences Center I Opinions are my own.

Atlanta, GA
Joined July 2009
Don't wanna be here? Send us removal request.
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
3 days
Important new report on invasive lobular breast cancer in the US. @JournalCancer @WinshipAtEmory @KalinskyKevin @TariKingMD @reshmajagsi @MylinTorres
@JournalCancer
ACS Journal Cancer
3 days
New @AmericanCancer report provides statistics on lobular breast cancer. Know the numbers: 🩺~11% of US breast cancers are invasive lobular carcinoma 📈 Incidence rising faster than other breast cancers 📊~33,600 diagnoses expected in 2025 https://t.co/TaWwnPO8qM @OncoAlert
0
1
7
@JournalCancer
ACS Journal Cancer
3 days
New @AmericanCancer report provides statistics on lobular breast cancer. Know the numbers: 🩺~11% of US breast cancers are invasive lobular carcinoma 📈 Incidence rising faster than other breast cancers 📊~33,600 diagnoses expected in 2025 https://t.co/TaWwnPO8qM @OncoAlert
3
13
24
@WaymoCommunity
Waymo community
4 days
Living with blindness or vision loss shouldn’t limit mobility. These riders say Waymo can help improve their independence.
0
2
11
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
4 days
The 15th annual ⁦@WinshipAtEmory⁩ 5K was a resounding success with >4200 participants. We exceeded our fundraising goal of $1M to support cancer research. Thanks to our patients, families, staff and researchers who made this possible. #winship5K@EmoryUniversity
2
1
13
@JournalCancer
ACS Journal Cancer
14 days
“The number of assessments for clinical trials has exploded... AI approaches can help reduce friction on the reproducible pain points.” @PatelOncology discusses the potential role of AI in clinical research in the latest CancerSpeak episode: https://t.co/UcgdctXmmD @OncoAlert
1
11
12
@BioAscend
BioAscend
30 days
🌟 Plenary Sessions Revealed at #ALCS2025🌟 Get ready for a comprehensive dive into the latest breakthroughs in lung cancer care: 🔹 Early-Stage/Locally Advanced #NSCLC: Multidisciplinary integration of neoadjuvant, surgical, & adjuvant therapies 🔹 Advanced NSCLC/SCLC 🔹
4
2
0
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 month
Worthy recipients of @IASLC distinguished awards! Congratulations to these amazing individuals. I am reminded of my first poster at WCLC with Dr. Dacic as co-author. @WinshipAtEmory
@StephenVLiu
Stephen V Liu, MD
1 month
Congratulations to the 2025 @IASLC, distinguished service award winners! Grateful for all the impact and happiness is the recognition at #WCLC25 for Drs. Sanja Dacic, Pasi Janne, @peters_solange and Wytold Rzyman!
8
5
39
@StephenVLiu
Stephen V Liu, MD
1 month
Congratulations to the 2025 @IASLC, distinguished service award winners! Grateful for all the impact and happiness is the recognition at #WCLC25 for Drs. Sanja Dacic, Pasi Janne, @peters_solange and Wytold Rzyman!
2
21
58
@POAUB
AUB Office of the President
1 month
Relive the highlights of the Festschrift honoring Dr. Fadlo R. Khuri. From thought-provoking panels to personal tributes, the event celebrated his enduring impact as a physician, leader, and mentor. #AUB #AUBproud
0
8
21
@WinshipAtEmory
Winship Cancer Institute of Emory University
1 month
🎉 Winship, through generous support from the @blankfoundation and in collaboration with @MountSinaiNYC, celebrated the launch of the new Winship Mobile Prostate Cancer Screening Program today at a community event. ➡️ https://t.co/okKPdqceIx #WinshipProstateCheck
9
6
9
@eaonc
ECOG-ACRIN Cancer Research Group
1 month
In our August newsletter, the co-chairs spotlight an open letter to Congress from the National Clinical Trials Network Cooperative Group Chairs, detailing its significant contributions to patient welfare. Read their editorial and the full letter here: https://t.co/YijQElKu3w
2
7
11
@RamalingamMD
Suresh S. Ramalingam, MD, FASCO
1 month
Memorable day ⁦@AUB_Lebanon⁩ at the Festschrift celebrating ⁦@DrFadloKhuri ‘s career as a scholar, mentor, leader and humanist. Joined by ⁦@wallyjc⁩ ⁦@teekayowo⁩ ⁦@DrRoyHerbstYale⁩ ⁦@AdamMarcusPhD⁩. ⁦@WinshipAtEmory⁩ ⁦@OtisBrawley
4
6
54
@WinshipAtEmory
Winship Cancer Institute of Emory University
2 months
🎉Winship researcher Chrystal Paulos, MD, (@Chrystal_Paulos) has been awarded a V Foundation All-Star Grant to accelerate immune-based treatment approaches in melanoma. 🔗 https://t.co/PV1ZADzptI
8
5
54
@JournalCancer
ACS Journal Cancer
2 months
New on CancerSpeak! Our Editor-in-Chief @RamalingamMD is joined by @weoncologists, @PatelOncology, and @ARosen380 to discuss key takeaways from #ASCO25. Topics include clinical trials, the role of AI, and patient-centered perspectives: https://t.co/UcgdctXmmD @OncoAlert
3
10
23
@LeciaSequist
Lecia Sequist, MD, MPH, FASCO
2 months
I absolutely can’t wait to read this new memoir out from my friend Dr. Nasser Hanna @hannawants2ELCN , a #LungCancer med onc who has been an inspiration and role to me for 20 years. His wisdom is unparalleled. Check it out!! Congrats Nasser!!! @ASCO @tmprowell @chrisdraft
8
17
66
@JournalCancer
ACS Journal Cancer
2 months
Thank you to our outstanding Section Editors and valued partners at @WileyOnc_Hem for making this year's @JournalCancer annual meeting a success! We look forward to continuing to bring the best of science to the broadest readership in support of the @AmericanCancer mission. 📗
1
8
27
@eaonc
ECOG-ACRIN Cancer Research Group
3 months
Read more from our co-chairs on the importance of protecting public support for biomedical research: https://t.co/iZjvYy1cKX #CancerResearch #ClinicalTrials
1
13
24
@JournalCancer
ACS Journal Cancer
3 months
Learn about Direct to CANCER, our new expedited review process for potentially practice-changing manuscripts that were rejected after peer review by high-impact journals for reasons of scope or priority. More here: https://t.co/fhjwPMn8wf @OncoAlert @RamalingamMD
0
5
9
@chadinabhan
chadi nabhan MD, MBA, FACP
3 months
Excited to welcome @WinshipAtEmory into the growing @RyghtAI Global Research Network - very much looking forward to working with @RamalingamMD @AjayNookaMD and colleagues to expedite clinical trial processes using generative AI technology. https://t.co/LAKPIlt3iC
Tweet card summary image
webwire.com
Ryght, a leader in real-time generative AI healthcare technology for clinical research, has announced that the prestigious Winship Cancer Institute of Emory University has joined its unique Ryght...
0
2
10
@Neil_Iyengar
Neil Iyengar, MD
3 months
I am delighted to join @WinshipAtEmory as co-director of breast oncology and director of cancer survivorship. Excited to join this team with deep and synergistic expertise where we will continue advancing cutting-edge science at the intersection of metabolic health and cancer!
@WinshipAtEmory
Winship Cancer Institute of Emory University
3 months
🎊Joining Winship on July 1, breast medical oncologist and cancer survivorship expert Neil M. Iyengar, MD, (@Neil_Iyengar) has been appointed director of survivorship services at Winship Cancer Institute of Emory University. Read more ➡️ https://t.co/sPSvg7wAL4
37
8
193
@WinshipAtEmory
Winship Cancer Institute of Emory University
4 months
Winship thoracic oncologists Jennifer Carlisle, MD, and Fatemeh Ardeshir, MD, presented their work during today’s afternoon poster session. Dr. Carlisle discussed the use of tarlatamab for SCLC in the outpatient setting and Dr. Ardeshir covered ctDNA in young-onset NSCLC. #ASCO25
1
5
22